SYDNEY--(BUSINESS WIRE)--Veeva Systems (NYSE: VEEV) today announced that contract research organisation (CRO) GenesisCare Clinical CRO, founded by GenesisCare, has adopted Veeva Vault eTMF, Veeva ...
The global research antibodies and reagents market is projected to grow at a CAGR of 7% from 2025 to 2030, driven by ...
Leading CRO using Veeva Vault eTMF, Veeva Vault CTMS, and Veeva Vault Payments to streamline clinical trial processes GenesisCare Clinical CRO provides an integrated CRO model with the GenesisCare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback